Pyrrolo [1,2-d][1,2-4]triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases

Details for Australian Patent Application No. 2005299730 (hide)

Owner Novartis AG

Inventors Dong, Qing

Agent Davies Collison Cave

Pub. Number AU-B-2005299730

PCT Pub. Number WO2006/047354

Priority 60/622,519 26.10.04 US

Filing date 25 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 12 November 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/047354 Priority application(s): WO2006/047354

12 November 2009 Application Accepted

  Published as AU-B-2005299730

18 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299731-Optically encoded glass-coated microwire

2005299724-Method for making an object from a product and object formed